Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Por um escritor misterioso
Descrição
Feng Ren LinkedIn
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. - Abstract - Europe PMC
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. - Abstract - Europe PMC
One-Pot 1,1-Dihydrofluoroalkylation of Amines Using Sulfuryl Fluoride
1-(3-tert-butylsulfonyl-4-cyano-2-hydroxyphenyl)-3 -[(1R)-2-methylcyclopent-2-en-1-yl]urea, C18H23N3O4S
Sophie GONG, Sr. scientist, GlaxoSmithKline, London, GSK, R&D China
PDF) CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis
Sophie GONG, Sr. scientist, GlaxoSmithKline, London, GSK, R&D China
Ting Yang's research works China Academy of Building Research Shanghai Branch, Shanghai and other places
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis - ScienceDirect
Development of fluorescent peptide G Protein Coupled Receptor activation biosensors for NanoBRET characterisation of intracellular allosteric modulators
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
de
por adulto (o preço varia de acordo com o tamanho do grupo)